Global Pharmerging Market Analysis, Trends, and Forecasts, 2019-2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmerging – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering.

Pharmerging market worldwide is projected to grow by US$780.7 Million, driven by a compounded growth of 10.9%.

Pharmaceutical, one of the segments analyzed and sized in this study, displays the potential to grow at over 9.5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$936.2 Million by the year 2025, Pharmaceutical will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 12.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$35.7 Million to the region’s size and clout in the next 5 to 6 years. Over US$36.1 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Pharmaceutical will reach a market size of US$69.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 10.5% over the next couple of years and add approximately US$133.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

• Abbott Laboratories
• AbbVie, Inc.
• Alexion Pharmaceuticals, Inc.
• Allergan PLC
• Amgen, Inc.
• Aspen Pharmacare Holdings Ltd.
• Astellas Pharma, Inc.
• AstraZeneca PLC
• Baxter International, Inc.
• Bayer AG
• Biogen, Inc.
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Celgene Corporation
• CSL Behring
• Daiichi Sankyo Co., Ltd.
• Eisai Co., Ltd.
• Eli Lilly and Company
• Endo International PLC
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC
• Grifols SA
• H. Lundbeck A/S
• Hospira, Inc.
• Johnson & Johnson
• Kyowa Hakko Kirin Co., Ltd.
• Mallinckrodt Pharmaceuticals
• Mitsubishi Tanabe Pharma Corporation
• Mylan Pharmaceutical Pvt. Ltd.
• Novartis AG
• Novo Nordisk A/S
• Otsuka Pharmaceutical Co., Ltd.
• Pfizer, Inc.
• Sanofi SA
• Shire PLC
• Stada Arzneimittel AG
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co., Ltd.
• Teva Pharmaceutical Industries Ltd.
• UCB SA

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Pharmerging Market to Grow Steadily, Driven by Rapid Growth of the Pharma Sector
• Worldwide Pharmaceutical Market Growth Projections by Regional Group: 2018 and 2022
• Breakdown of Growth Percentage and Spending in Billion USD for Pharmerging Markets by Country: 2007-2022
• Global Competitor Market Shares
• Pharmerging Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Pharmaceutical Segment to Register Strong Growth
• Total Spending on Medicines (in Billion USD) in Select Emerging Pharmaceutical Markets: 2023
• Healthcare Market in Tier I Pharmerging Region (USD Billion) by Product: 2014-2025
• Asia-Pacific Region to Retain Top Slot

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Growing Geriatric Population to Bode Well for Market Growth
• Total Breakdown of People Aged Over 60 by Development Groups: 1980 to 2050
• Increase in Patient Numbers to Support Market Growth
• Top Therapeutic Areas by Spending (Billion USD) in Pharmerging Markets: 2018
• Select Therapy Areas Spending (Billion USD) in Pharmerging Markets: 2020
• Increasing Preference for Generics to Spur Market Expansion

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

• Market Facts & Figures
• US Pharmerging Market Share (in %) by Company: 2019 & 2025
• Market Analytics

CANADA

JAPAN

CHINA

EUROPE

• Market Facts & Figures
• European Pharmerging Market: Competitor Market Share Scenario (in %) for 2019 & 2025
• Market Analytics

FRANCE

GERMANY

ITALY

UNITED KINGDOM

REST OF EUROPE

ASIA-PACIFIC

REST OF WORLD

IV. COMPETITION

V. CURATED RESEARCH

For more information about this report visit https://www.researchandmarkets.com/r/licn5t

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900